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Abbreviations 
AMPK AMP-activated protein kinase  
AP-1 activator protein 1  
BMDC bone marrow-derived dendritic cell 
CREB cAMP-responsive element-binding protein  
DC dendritic cell 
ERK extracellular signal–regulated kinase 
GAP GTPase-activating protein 
GEF guanine nucleotide exchange factor 
GM-CSF granulocyte-macrophage colony-stimulating factor  
GSK glycogen synthase kinase 
HILIC hydrophilic interaction chromatography 
IFN-β interferon-β 
IKK inhibitor of NF-κB kinase  
JNK c-Jun N-terminal kinase 
LPS lipopolysaccharide 
MAPK mitogen-activated protein kinase  
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MAPKAPK MAPK-activated protein kinase 
MOI multiplicity of infection  
mTOR mammalian target of rapamycin 
NF-κB nuclear factor κ-light-chain-enhancer of activated B cells  
p70S6K p70 ribosomal S6 kinase  
PAK p21-activated kinase 
PI3K phosphoinositide 3-kinase 
RSK p90 ribosomal protein S6 kinase 
SILAC stable isotope labeling by amino acids in cell culture 
TLR toll-like receptor 
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Summary 
Dendritic cells (DCs) infected by Francisella tularensis are poorly activated and do not undergo 
classical maturation process. While reasons of such unresponsiveness are not fully understood, 
their impact on the priming of immunity is well appreciated. Previous attempts to explain the 
behavior of Francisella-infected DCs were hypothesis-driven and focused on events at later 
stages of infection. Here, we took an alternative unbiased approach by applying methods of 
global phosphoproteomics to analyze the dynamics of cell signaling in primary DCs during the 
first hour of infection by Francisella tularensis. Presented results show that the early response of 
DCs to Francisella occurs in phases and that ERK and p38 signaling modules induced at the 
later stage are differentially regulated by virulent and attenuated ΔdsbA strain. These findings 
imply that the temporal orchestration of host pro-inflammatory pathways represents the integral 
part of Francisella life-cycle inside hijacked DCs. 
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Introduction 
Francisella tularensis is a Gram-negative bacterium and intracellular pathogen that is 
responsible for tularemia disease (1). Although humans are not the primary hosts, Francisella 
capacity to cause respiratory infections with the relatively high mortality rates prompted the 
classification of the bacterium as a potential biological weapon (2). The disease itself is 
characterized by the delayed onset of the adaptive immunity which is then followed by the 
hypercytokinemia (3). The sub-optimal host response comes as a consequence of Francisella 
ability to avoid the activation of phagocytes in which the bacterium replicates (4). Francisella 
initiates its intracellular life cycle by the entry into the host cell where it transiently resides 
within the phagosome. Following 30-60 minutes post infection (p.i.), Francisella escapes from 
the vacuole into the host cell cytosol and it replicates there (5). Dendritic cells (DCs), as 
professional phagocytes, are also susceptible to Francisella infection. In similar to the situation 
in other host cells, Francisella-infected DCs are not sufficiently stimulated, do not produce pro-
inflammatory cytokines and do not undergo the classical process of maturation (6). 
Consequently, these DCs have only a limited capacity to prime the adaptive response and they 
serve rather as migrating bacterial reservoirs. The weak immunostimulatory phenotype of 
infected DCs correlates with Francisella tendency to evade the host pro-inflammatory signaling. 
Francisella-mediated activation of nuclear factor κ-light-chain-enhancer of activated B cells 
(NF-κB) is dependent on toll-like receptor 2 (TLR2)/myeloid differentiation primary response 
protein 88 (MyD88) stimulation (7). However, the bacterium is able to reduce the NF-κB-driven 
gene expression either through the modulation of phosphoinositide 3-kinase (PI3K)/Akt pathway 
or by the rapid escape from the phagosome (7, 8). In cytosol, the sensing of Francisella DNA 
triggers stimulator of interferon genes (STING)-dependent type I interferon (IFN) response 
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which helps to orchestrate the inflammasome assembly and caspase 1 activation (9, 10). 
Nevertheless, although virulent Francisella stimulates in DCs the expression of IFN-β, the 
pyroptosis is suppressed (11). Francisella manipulation of DC response therefore evolves in time 
and follows the bacterial needs. From this perspective, the early Francisella-DC interactions 
represent the crucial phase which directs the future events of DC activation and potentially 
shapes the adaptive immune response. 
To better understand these early processes, we analyzed the cell signaling dynamics of primary 
DC during the first hour of Francisella infection by SILAC (stable isotope labeling by amino 
acids in cell culture) based phosphoproteomic approach. Our results reveal the existence of 
distinct phases of protein phosphorylation in infected DCs. While the initial stage seems to be 
connected with the general process of the bacterial entry, the induction of extracellular signal–
regulated kinase (ERK) and p38 signaling during the later phase is regulated differently by the 
used virulent and attenuated Francisella strains. 
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Experimental procedures 
Cultivation of bacteria 
All Francisella tularensis strains were cultured on McLeod agar enriched for bovine hemoglobin 
and Iso-Vitalex (both Becton Dickinson) at 37 °C. 
Generation/SILAC labeling of bone marrow-derived DCs (BMDCs) and J774.2 cultivation 
BMDCs were generated from bone marrow progenitors isolated from femurs and tibias of 6- to 
8-week-old female C57BL/6 mice. Approximately 1 × 107 bone marrow cells were seeded on 10 
cm tissue plastic Petri dish into 10 mL of RPMI-1640 media containing 10% (v/v) fetal bovine 
serum (FBS; Sigma Aldrich) and penicillin/streptomycin and these were left at 37 °C in a 
humidified atmosphere of 5% CO2. After overnight depletion of adherent cells, suspension cells 
were seeded on a new dish in RPMI-1640, 10% FBS, and 5% (v/v) supernatant from Ag8653 
cells transfected by cDNA of murine granulocyte-macrophage colony-stimulating factor (GM-
CSF). Cells were passaged every 2−3 days. Suspension cells were harvested on the day 9 of 
cultivation. SILAC labeling of BMDCs was performed as previously described (12). All 
experiments using mice were performed in accordance with guidelines of the Animal Care and 
Use Ethical Committee of the Faculty of Military Heath Sciences, University of Defense, Czech 
Republic (project no. 50-6/2016-684800). The murine macrophage-like cell line J774.2 was 
obtained from the European Collection of Cell Culture (EACC, ref No. 85011428). J774.2 were 
cultured in high glucose DMEM containing 10% (v/v) FBS (Sigma Aldrich) and kept at 37 °C in 
a humidified atmosphere of 5% CO2. Cells were passaged every 2-3 days. 
Infections and treatments 
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Unless otherwise noted, all infection experiments were done as described: harvested BMDCs 
were seeded into fresh RPMI-1640 medium containing 10% FBS (or SILAC medium with 10% 
dialyzed FBS in the case of proteomics experiments) at 2.5 × 106 cells/ml. Infection was initiated 
by the addition of bacteria suspended in the medium of the same composition followed by 
thorough mixing. Multiplicity of infection (MOI) was 50. Infected cells were kept at 37 °C/5% 
CO2 and the infection was stopped by the addition of excess of ice-cold PBS followed by 
centrifugation of suspension at 4 °C. For 24 h infection intervals, BMDCs were seeded at 2 × 106 
cells/ml and MOI was 10. Cells treated by E. coli 055:B5 lipopolysaccharide (LPS; 500 ng/ml) 
were used as a positive control. In experiments with killed Francisella, bacteria were first fixed 
by 3.7% (w/v) paraformaldehyde (PFA) at 4 °C overnight and then used as an infection agent at 
apparent MOI 100. For synchronization of BMDC infection, bacterial suspension was mixed 
with the suspension of 7.5 × 106 cells (MOI 50) in flat-bottom falcon tube and immediately co-
pelleted in centrifuge (400 g, 5 min, RT). Following the centrifugation (t = 0), cells were kept at 
37 °C/5% CO2 for the indicated time p.i. Mock-infected BMDCs were centrifuged without 
bacteria. When indicated, seeded BMDCs were pre-treated either by DMSO or by bafilomycin 
A1 or SB203580 (both Sigma Aldrich) for 1 hour at final concentrations of 100 nM or 10 μM, 
respectively, followed by the addition of bacteria. DMSO/inhibitors were present in the medium 
throughout the infection. Adherent J774.2 cells were infected in 6-well plates (1× 106 cells/well) 
by co-centrifugation (400g, 5 min, RT) with bacteria (MOI 50) and left for 60 min at 37 °C/5% 
CO2. 
Cell lysis and protein digestion 
BMDC pellets were lysed by sodium deoxycholate (SDC)-containing buffer as previously 
described (13). Protein concentrations were measured using the Micro BCA kit (Thermo Pierce) 
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and the corresponding light and heavy isotope-labeled lysates were mixed in a 1:1 ratio based on 
protein content. Proteins were reduced by the addition of DTT (final concentration 10 mM) for 1 
h at 37 °C, followed by the alkylation with iodoacetamide (IAA; final concentration 20 mM) for 
30 min at room temperature in the dark. The excess of IAA was quenched by the addition of 
DTT to a final concentration of 20 mM and the reaction was left to proceed for 15 min at room 
temperature. Proteins were digested by trypsin (Promega) at a ratio 50:1 (w/w) at 37 °C 
overnight. Digestion was stopped by the addition of TFA to a final concentration of 1% (v/v) to 
precipitate SDC. Suspension was then mixed with an equal volume of ethyl acetate, vortexed and 
centrifuged. Upper organic phase was removed and the extraction process was repeated four 
times to completely extract SDC (14). Water phase containing peptides was then desalted on 
Discovery DSC-18 SPE cartridges (500 mg/3 mL; Sigma Aldrich) and the eluate in 80% 
ACN/0.1% TFA was vacuum dried. 
HPLC fractionation 
Fractionation of peptides was done using Alliance 2695 liquid chromatograph (Waters). For 
phosphoproteome analysis, BMDC digests were fractionated by hydrophilic interaction 
chromatography (HILIC) (15). Peptide material of 3 to 5 mg was injected onto TSKgel Amide-
80 HR column (5 μm, 4.6 × 250 mm) with guard column (5 μm, 4.6 × 10 mm; both Tosoh 
Bioscience) under conditions of 20% mobile phase A (2% ACN/0.1% TFA) and 80% mobile 
phase B (98% ACN/0.1% TFA) at flow rate of 0.5 mL/min. Peptide separation was performed by 
a linear gradient formed by mobile phase A and mobile phase B, from 80 to 60% of mobile 
phase B in 40 min and from 60 to 0% of mobile phase B in 5 min. Through the gradient elution 
window, 20 fractions were manually collected into microcentrifuge tubes. For analysis of BMDC 
proteome at 60 min p.i., 200−300 μg of peptides were fractionated by high-pH reversed phase 
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liquid chromatography as previously described (16) and 10 fractions were manually collected 
through the gradient elution window. Prior LC-MS analysis, fractions 1 and 2 were pooled with 
fractions 9 and 10, respectively. 
Phosphopeptide enrichment 
Collected HILIC fractions were first acidified by 2% (v/v) TFA solution containing 100 mM 
glutamic acid as an excluder, followed by the addition of 1.5−2.5 mg of TiO2 particles (10 μm, 
GL Sciences). Suspensions were then vortexed for 20 min at room temperature and centrifuged. 
Pellets of TiO2 were sequentially washed in buffers A (65% ACN/2% TFA/100 mM glutamic 
acid), B (65% ACN/0.5% TFA), and C (65% ACN/0.1% TFA). TiO2-bonded phosphopeptides 
were eluted by vortexing particles for 10 min at room temperature in ammonia solution (pH ≈ 
11) followed by the acidification of supernatants by TFA to reach pH 2. Each HILIC fraction 
was subjected to two identical cycles of the enrichment and TiO2-eluates from the same fraction 
were pooled, desalted on 3M Empore SPE cartridges (Sigma Aldrich) and the eluates in 65% 
MeOH/0.1% TFA were vacuum-dried. 
Liquid chromatography-mass spectrometry 
The Ultimate 3000 RSLCnano system connected through Nanospray Flex ion source with Q 
Exactive mass spectrometer (Thermo Scientific) were used for instrumental analysis (17). For 
phosphoproteome analysis, approximately one third of sample material from each 
phosphopeptide fraction was introduced onto trap column (PepMap100 C18, 3 μm, 0.075 × 20 
mm) and then separated by running a linear gradient (0.1% FA in water as phase A; 80% ACN, 
20% water and 0.1% FA as phase B) from 4 to 34% B in 48 min and from 34 to 55% B in 10 
min, at a flow rate of 300 nL/min, on analytical column (PepMap C18, 2 μm, 0.075 × 150 mm). 
11 
 
The full MS/Top10 setup was used for mass spectra acquisition. The positive ion MS spectra 
from 350-1750 m/z range were obtained in the Orbitrap at a resolution of 70,000 (at m/z 200). 
Multiply charged precursors ions with minimal threshold intensity of 5×104 counts and not 
fragmented during previous 30 s were admitted for higher energy collisional dissociation (HCD). 
Tandem mass spectra were acquired with following settings; resolution at 17,500, AGC target 
value at 1×105, maximum ion injection time at 100 ms, and normalized collision energy set to 
27. Data acquisition was under control of Xcalibur software v3.0. Proteome samples fractions 
were analyzed by the same instrumentation using a linear gradient from 4 to 30% B in 88 min 
and from 30 to 55% B in 25 min for separation. Mass spectrometer operated in Top12 setup and 
collected MS spectra were in range of 350-1650 m/z. Intensity threshold for triggering MS/MS 
was 6×104 counts. The rest of instrumental parameters were identical to those of 
phosphoproteome analysis. 
Phosphosite and protein identification and quantification 
Phosphoproteome and proteome datasets were processed by MaxQuant ver. 1.5.2.8 coupled with 
Andromeda search engine (18). Data were searched against FASTA database consisting of 
reference proteome for Mus musculus (UP000000589; June 16, 2015; 53,245 sequences) and 
Swiss-Prot + TrEMBL database entry for Francisella tularensis subsp. holartica FSC200 strain 
(January 27, 2015; 1424 sequences), both downloaded from Uniprot site. MaxQuant-
implemented database was used for the identification of contaminants. False discovery rate 
(FDR) estimation of peptide identification was based on target-decoy approach using reverted 
search database as a decoy. Phosphosite identification and quantification was done using these 
MaxQuant parameters: mass tolerance for the first search 20 ppm, for the second search from 
recalibrated spectra 4.5 ppm (with individual mass error filtering enabled); maximum of 2 
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missed cleavages; maximal charge per peptide z = 7; minimal length of peptide 7 amino acids, 
maximal mass of peptide 4600 Da; carbamidomethylation (C) as fixed and phosphorylation 
(STY), oxidation (M) and acetylation (protein N-term) as variable modifications with the 
maximum number of variable modifications per peptide set to 5. Trypsin with no cleavage 
restriction was set as a protease. Mass tolerance for fragments in MS/MS was 20 ppm, taking the 
12 most intensive peaks per 100 Da for search (with enabled possibility of co-fragmented peptide 
identification). Minimal Andromeda score for modified peptides was 40 and minimal delta score 
for modified peptides was 6. FDR filtering on peptide spectrum match was 0.01 with separate 
FDR filtering for each modification set to 0.01. For peptide quantitation, Arg+6 [13C6] and Lys+6 
[13C6] were set as labels in heavy channel (or in light channel for label-swap experiments to 
obtain inverted H/L ratios) with re-quantify function enabled. Ratios for individual phosphosites 
were derived from normalized ratios of the least modified phosphopeptides in a given replicate. 
MaxQuant parameters for processing of proteome data were identical except for only oxidation 
(M) and acetylation (protein N-term) were allowed as variable modifications. For protein 
quantitation, only protein groups with at least one unique or razor peptide having SILAC ratio 
and only those protein groups passing protein FDR filtering set to 0.01 were considered (18). All 
hits identified in searches as contaminants were filtered out. 
Experimental design and statistical rationale 
SILAC experiments were performed in biological triplicate for each time point and bacterial 
strain used and the respective mock-treated BMDCs served as a control. In two replicates, light 
BMDCs were infected and heavy cells were mock-treated. In one replicate, SILAC groups were 
swapped (Fig. S1). In total, 18 digests (three time points/two bacterial strains/triplicate) were 
fractionated by HILIC. Aliquots of 6 digests (60 min p.i./two bacterial strains/triplicate) were 
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also subjected to proteome analysis. Significantly regulated phosphosites for each triplicate (time 
point/bacterial strain) were found by global mean rank test (GMRT) (19) using R package 
MeanRankTest (https://www.evotec.com/MeanRankTest) with parametric FDR level set to 0.05. 
Only those phosphosites quantified in all three replicates of the given experimental condition 
were allowed for testing. With respect to the obtained phosphoproteomic data, GMRT was 
chosen for two reasons: i) rank tests in general are advantageous for global methods when fold 
changes are relatively low (20) and ii) GMRT was shown to reliably control FDR even for small 
number of replicates (19). 
Phosphosite fuzzy c-means clustering 
Fuzzy c-means clustering (21) of phosphosites with localization probability >0.75 (22, 23), 
which were quantified in all three time points for WT-infected BMDC samples with the relative 
standard deviation (RSD) <30%, was done by Mfuzz R package (24). For a given phosphosite, 
normalized log2-ratios from replicates were first averaged and multiplied by -1 for each time 
point and then normalized by Z-score. Fuzzifier was set to 3.65 (25) and the number of clusters 
was 4. Human protein reference database (HPRD) (26) kinase motifs enriched in phosphosite 
clusters were found by Fisher exact test (Benjamini-Hochberg (BH) FDR level set to 0.05) using 
Perseus software ver. 1.5.4.1 (27).  
InnateDB terms enrichment and the construction of protein-protein interaction network 
For the comparison of BMDC response induced by WT and ΔdsbA Francisella strains, 
normalized log2-ratios of phosphosites quantified in all three replicates of WT-infected BMDCs 
samples were tested by unpaired two sample Student’s t test against those quantified in all three 
replicates of ΔdsbA-infected BMDCs samples of the same time interval. Phosphosites (and 
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corresponding phosphoproteins) having p <0.05 were further considered as differentially 
regulated between BMDCs infected by WT and ΔdsbA. For InnateDB term analysis, 
phosphoproteins were first annotated by Pathway analysis web-based tool from InnateDB 
database (http://www.innatedb.com/) (28) and Fisher exact test was then used to find enriched 
InnateDB Pathway name terms in the group of differentially regulated phosphosites (BH FDR 
level set to 0.05). Only terms containing at least 3 regulated phosphosites are reported. In case 
where the same group of phosphosites was annotated by several similar enriched InnateDB 
terms, one representative term was selected. Using the described approach, none InnateDB terms 
were found enriched for 10 and 30 min p.i. For the construction of protein-protein interaction 
network, only proteins bearing phosphosites differentially regulated between WT- and ΔdsbA-
infected BMDCs at 60 min p.i. were considered. Sequences were mapped to murine protein 
sequences on STRING (v10) (29) using BLAST to obtain database identifiers and best matches 
with at least 80% identity were used. STRING interaction network containing interactions with 
>700 score was then loaded into Cytoscape ver 3.2.1 and only differentially regulated 
phosphoproteins or proteins having at least two differentially regulated neighbors (“connecting” 
nodes) were kept. The emerging network was then reduced to contain smallest possible number 
of “connecting” nodes while keeping all regulated phosphoproteins in one network (i.e. 
removing “connecting” nodes with relatively low number of neighbors). In cases where could 
not be decided, all equivalent nodes were kept. 
Immunofluorescence microscopy 
Bacteria were incubated for 1 h with 5 μM 5-(and 6)-carboxyfluorescein diacetate succinimidyl 
ester (CFDA-SE) prior the infection. BMDCs were then infected as described in Experimental 
procedures, transferred to glass slide using cytospin and fixed by 3.7% PFA. The excess of PFA 
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was quenched by 50 mM NH4Cl and cells were permeabilized by 50 μg/ml digitonin for 1 min. 
BMDCs were then stained for 20 min by Alexa Fluor 594 Phalloidin (6.6 μM) and for 5 min by 
4',6-diamidino-2-phenylindole (DAPI, 300 nM) and mounted by Mowiol. Microscope slides 
were viewed by fluorescence microscopy on Nikon Eclipse Ti (Nikon, Tokyo, Japan). 
Percentage of infected cells was calculated as an average of 500 cross-sectional images per time 
point. 
Transmission electron microscopy 
Infected of uninfected cells were quickly washed with Sörensen buffer (0.1 M sodium/potassium 
phosphate buffer, pH 7.3; SB) at 37 °C, fixed with 2.5% glutaraldehyde in SB for 2 h, washed 
with SB, embedded in blocks of 1% low-melting point agarose (type VII, Sigma Aldrich), and 
postfixed with 1% OsO4 solution in SB for 2 h. The cells were dehydrated in series of ethanol 
with increasing concentration, subsequently in propyleneoxide, and embedded in Epon-
Durcupan resin. Polymerized blocks were cut into 80 nm ultrathin sections, collected on 200 
mesh size copper grids, and stained with saturated aqueous solution of uranyl acetate for 4 min. 
The sections were examined in FEI Morgagni 268 transmission electron microscope operated at 
80 kV. The images were captured using Mega View III CCD camera (Olympus Soft Imaging 
Solutions). 
Flow cytometry 
Following 24 h of infection, suspension BMDCs were harvested and stained by following 
antibodies: anti-CD11c-phycoerythrin (PE)-Cy7 (BD Pharmingen), anti-CD80-PE (Beckman 
Coulter), anti-CD86-PE (Beckman Coulter), and anti-I-A/I-E major histocompatibility complex 
II (MHC II) conjugated with biotin (Novus Biologicals), respectively. Anti-MHC II antibodies 
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were then stained by streptavidin-FITC (Invitrogen). Cells were fixed and before analysis on 
CyAn ADP flow cytometer (Beckman Coulter) stained by propidium iodide. Data acquisition 
and interpretation were done using Summit 4.3 software (Beckman Coulter). 
ELISA 
Quantification of cytokines in cell culture supernatants was done using DuoSet ELISA kits 
(R&D Systems) according to manufacturer instructions. 
Quantitative real-time PCR 
RNA was isolated from cells using RNeasy kit from Qiagen. 1 μg of total RNA was reverse 
transcribed using oligo (dT) primers (New England Biolabs). Quantitative real-time PCR 
analysis was performed and analyzed using ABI Prism 7500 Fast RT-PCR System (Applied 
Biosystems). Data were normalized to the housekeeping gene 18S rRNA (Rn18S1) and 
expressed as fold change relative to RNA samples from mock-treated cells using the comparative 
Ct method (ΔΔCt). The following TaqMan Gene Expression Assays were used (Applied 
Biosystems): Il10 (Mm01288386_m1), Il12b (Mm01288989_m1), Ifnb1 (Mm00439552_s1), and 
Rn18S1 (Mm03928990_g1). 
Western blot 
Cell pellets were lysed in RIPA buffer containing protease (Roche) and phosphatase (cocktail set 
II, Merck) inhibitors. Denatured and reduced proteins were separated by SDS-PAGE and 
transferred to PVDF membranes. Blots were blocked by milk and incubated with primary 
antibody overnight followed by secondary antibody conjugated with horse-radish peroxidase 
(Dako). Bands were visualized by ECL (Amersham). Anti-β-actin and anti-tubulin antibodies 
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were purchased from Sigma Aldrich and Abcam, respectively. The rest of primary antibodies 
were obtained from Cell Signaling. 
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Results 
Francisella induces two waves of protein phosphorylation in BMDCs during the first hour 
of infection 
SILAC-labeled primary murine bone marrow-derived DCs (BMDCs) (12) were infected by fully 
virulent Francisella tularensis subsp. holarctica FSC200 strain (WT) in suspension without the 
synchronization by centrifugation to avoid TLR2-MyD88-dependent NF-κB activation caused by 
a mechanical force (30). BMDCs were lysed at 10, 30, and 60 min p.i. and the lysates were 
processed and analyzed as described in Experimental procedures (Fig. S1). In total, 17,535 
phosphosites from Francisella-infected BMDC proteome were identified. From these, more than 
5,000 were quantified in all replicates of each experimental condition (time/bacterial strain; Fig. 
S2 and Table S1). In general, Francisella-induced phosphorylation events in BMDCs were most 
apparent at 10 min p.i. (Fig. 1A). Consistently, the highest number of phosphosites was classified 
as significantly regulated at 10 min p.i. (Fig. 1B and Fig. S3). Surprisingly, following the drop at 
30 min p.i., there was a new increase in BMDC protein phosphorylation at 60 min p.i. This 
observation was not caused artificially by the variability of data. Phosphoproteome samples were 
grouped together according to the time p.i. in PCA (Fig. S4A). Although the relatively small 
phosphorylation changes and sub-optimal SILAC labeling efficiency of primary BMDCs (12) 
led to the low correlation of label swap replicates, there was no difference between 30 and 60 
min p.i. datasets in terms of the distribution of RSDs for phosphosites SILAC ratios (Fig. S4B). 
The increase in BMDC signaling at 60 min p.i. was also not affected by the changes in protein 
expression or degradation (Fig. S5). To further analyze phosphorylation dynamics in infected 
BMDCs, fuzzy c-means clustering was used to group reproducibly quantified phosphosites 
according to their time profiles (Fig. 1C and 1D). In line with results shown in Fig. 1B, cluster 
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peaking at 10 min p.i. (cluster A) contained the highest number of phosphosites (Fig. 1C). To 
identify potentially involved kinases, clustered phosphosites were searched for Human Protein 
Reference Database (HPRD) kinase motifs (Table 1) and prevalent sequence features were 
assembled for each cluster. Activities of several kinases seemed to follow the profile of the 
largest phosphosite cluster A; e.g. p70 ribosomal S6 kinase (p70S6K), Akt or p21-activated 
kinase 2 (PAK2) (Table 1). Importantly, activities of these kinases were confirmed by Western 
blot (Fig. 1E). The large part of phosphoproteins regulated at 10 min p.i. was functionally linked 
to regulation of cytoskeleton and vesicular transport (Table S1). Among them, GTPase-
activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs) of Rac and Cdc42 
GTPases (e.g. Arhgaps, Arhgefs or Docks) represented the most notable examples. GEFs 
activate Rac/Cdc42 and promote their binding to PAKs, which in turn stimulates PAK 
autophosphorylation and activation. Such autophosphorylation of PAK1 (S204) and PAK2 (S55 
and S197) was indeed detected at 10 min p.i., therefore indirectly confirming previous kinase 
motif analysis (Fig. 1D, 1E and Table 1) and supporting the active role of Rho GTPase-PAK 
signaling in Francisella internalization. In contrast to 10 min p.i., only few potential kinases 
could be associated with the second signaling maximum occurring 60 min p.i. (clusters B and D 
in Fig. 1D and Table 1, respectively). While the activity of AMP-activated protein kinase 
(AMPK) gradually increased and peaked at 60 min p.i. (cluster D in Fig. 1D and Fig. 1E), ERKs 
displayed more complex behavior as their kinase motif was enriched in phosphosite cluster 
displaying maxima at 10 min and 60 min p.i. (cluster B in Fig. 1D). 
Francisella mutant lacking dsbA gene may serve as an avirulent control to WT strain in 
BMDCs 
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The identification of DC signaling pathways regulated in response to Francisella virulent 
behavior could be facilitated by the confrontation of results with experiments where attenuated 
strain was used as a control. Francisella strains lacking dsbA gene (ΔdsbA) are attenuated in vivo 
and provide the protection against subsequent challenge by parental strain (31–33). The 
engagement of adaptive immunity suggests that ΔdsbA would represent suitable alternative to 
WT in terms of DC response. To assess in vitro ability of ΔdsbA to induce BMDC maturation, 
cells were infected by FSC200 WT and ΔdsbA mutant of the same background and surface 
expression of MHC II, CD80 and CD86 was measured 24 h p.i. by flow cytometry (Fig. 2A). For 
all presented maturation markers, ΔdsbA-infected BMDCs showed higher expressions than cells 
infected by WT. Similarly, in vitro secretion of pro-inflammatory cytokines IL-12p40, IL-1β and 
IL-6 was higher in BMDCs infected by ΔdsbA at 24 h p.i. (Fig. 2B). The observed differences 
between strains were not skewed by BMDC cell death (Fig. S6A). Note however, that both WT 
and ΔdsbA strains were relatively poor inducers of BMDC cytokine secretion compared to 
Francisella Live Vaccine Strain (LVS; Fig. 2B). Moreover, the viability of cells in general (Fig. 
S6A) might further affect the cytokine production since the levels of IL-12p40 secreted by 
ΔdsbA-infected BMDCs did not exceed those of uninfected cells and the production in WT-
infected BMDCs was even lower (Fig. 2B). Consistently, the levels of IL-12p70 and IL-23 
secreted by BMDCs infected with either WT or ΔdsbA were below the level of detection. To 
explore the intracellular fate of bacterial strains, WT- and ΔdsbA-infected BMDCs were 
subjected to transmission electron microscopy at 60 min p.i. Similarly to what was previously 
reported (34), WT bacteria were located primarily in the cytosol at this time p.i. (Fig. 2C). In 
contrast, the majority of ΔdsbA bacteria (~60%) were surrounded by the damaged vacuolar 
membrane (Fig. 2C) which suggested the intracellular trafficking of ΔdsbA in BMDCs differed 
21 
 
from that of virulent strain. Importantly, while the unsynchronized infection reduced BMDC 
infectivity, the dynamics of WT and ΔdsbA host entry did not differ significantly (Fig. S6B). 
Taken together, the results confirmed the attenuated nature of ΔdsbA in BMDCs in vitro and 
encouraged its use as an avirulent control for phosphoproteomics experiments where WT was an 
infection agent (Fig. S1). 
Signaling of mTOR/p70S6K is sustained 60 min p.i. in WT-infected BMDCs 
BMDCs infected by ΔdsbA mutant were processed and analyzed for phosphoproteome changes 
exactly as for WT-treated cells. Dominant feature of WT-infected BMDCs was an early Akt 
activation (see above) (8). To examine whether WT and ΔdsbA mutant differed in their ability to 
trigger Akt signaling, time profiles of several identified Akt targets phosphorylated in both WT- 
and ΔdsbA-infected BMDCs at 10 min p.i. were compared (Fig. 3A, Table S1). Phosphorylation 
trends of Tuberin (Tsc2; T1465), proline-rich AKT1 substrate 1 (PRAS40; T247), glycogen 
synthase kinase-3 β (GSK-3β; S9) or AMPK α1 (S496) followed the predicted Akt activity 
(cluster A in Fig. 1D) similarly in both WT- and ΔdsbA-infected BMDCs. Importantly, these 
proteins are responsible for the suppression of mammalian target of rapamycin complex 1 
(mTORC1) activity and Akt-mediated phosphorylation release mTORC1 from their inhibition 
(35–38). This suggested that mTOR activity should follow that of Akt in both WT- and ΔdsbA-
infected BMDCs (Fig. 1D). However, several phosphosites associated with mTOR signaling 
were found to be upregulated at 60 min p.i. in BMDCs infected by WT (Fig. 3B, Table S1). 
While phosphorylation of mTOR on S1261 was shown to be crucial for the induction of 
mTORC1 activity (39), functional roles of phosphosites S278 on SH3 domain-binding protein 4 
(SH3BP4) and S381 on RagC are unknown. Interestingly, SH3BP4 negatively regulates 
mTORC1 activity on lysosome lumen through binding of Rag complex via SH3BP4 region 
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containing S278 (40). Differential regulation of mTOR between WT- and ΔdsbA-infected 
BMDCs at 60 min p.i. was confirmed by Western blot (Fig. 3C). Independently of the bacterial 
strain used, PRAS40 (T247) phosphorylation (compare with Fig. 3A) and mTOR/p70S6K 
signaling were induced 10 min p.i. However, mTOR/p70S6K crosstalk at 60 min p.i. was 
preserved only in WT-infected BMDCs. These results suggest that in contrast to BMDCs 
infected by ΔdsbA, mTOR/p70S6K signaling is maintained in WT-infected BMDCs at 60 min 
p.i. and that this activity is Akt-independent. 
Cell signaling of BMDCs infected by WT and ΔdsbA starts to diverge at 60 min p.i. 
Observed differences in mTOR activity prompted further inspection of phosphoproteomic data to 
search for system-wide variations in WT- and ΔdsbA-induced BMDC signaling. To determine 
correlations in phosphoproteomes, phosphosites quantified in the given time point p.i. in both 
WT- and ΔdsbA-infected BMDCs were plotted against each other in scatter plots (Fig. 4A). 
Phosphorylation changes induced by WT and ΔdsbA invasion at 10 min p.i. correlated well. 
However, WT-infected BMDCs showed more prominent protein phosphorylation with 
increasing time p.i. (Fig. 4A). This behavior affected also counts of regulated phosphosites (Fig. 
S3 and Table S1). While at 10 min p.i. the numbers of significantly regulated phosphosites in 
BMDCs infected by WT and ΔdsbA were comparable, almost three times more phosphosites 
from WT-infected cells passed the significance test when compared to ΔdsbA at 60 min p.i. (Fig. 
S3). Similarly, the numbers of phosphosites, which were considered as differentially regulated 
between WT- and ΔdsbA-infected BMDCs (see Experimental procedures), were almost two 
times higher at 60 min p.i. (125 sites) than those at 10 or 30 min p.i. (70 and 56, respectively; 
Fig. S7). Interestingly, the weak correlation of strain-specific signaling temporally corresponded 
to the second wave of protein phosphorylation at 60 min p.i. in WT-infected BMDCs (Fig. 1B). 
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BMDC signaling pathways engaged differentially by WT and ΔdsbA at 60 min p.i. were found 
by InnateDB terms enrichment analysis (Fig. 4B). Taken together, WT and ΔdsbA induce similar 
patterns of protein phosphorylation in BMDCs during the entry. BMDC cell signaling start to 
diverge in later time points p.i. and this is largely due to activation of TLR- and mitogen-
activated protein kinase (MAPK)-related pathways in WT-infected cells. 
ERKs and p38 modules are major components of WT-induced BMDC signaling at 60 min 
p.i. 
To explore phosphoproteins differentially regulated at 60 min p.i. to a greater depth, protein-
protein interaction network was constructed (Fig. S8). The assembly of the network was 
subjected to two requirements: i) the network should contain as many phosphoproteins 
differentially regulated in WT- and ΔdsbA-infected BMDCs at 60 min p.i. as possible and ii) 
unidentified proteins should also be included to keep the network together (see Experimental 
procedures). Notably, the center of the network was formed by a cluster of closely interacting 
nodes corresponding to MAPKs and MAPK-activated protein kinases (MAPKAPKs) (Fig. 5A). 
The kinetics of phosphorylation for sites with available quantitative data is shown in Fig. 5B. 
The phosphorylation profiles of ERK2 and p38α in their activation loops (Y185 and T180, 
respectively) suggested that these MAPKs are activated at 60 min p.i. only in WT-infected 
BMDCs. Interestingly, while the activation of p38α in WT-infected BMDCs peaked at 60 min 
p.i., the phosphorylation of ERK2 was upregulated also at 10 min p.i. in both WT- and ΔdsbA-
infected BMDCs. Of note, the time profile of ERK2-activation phosphosite in WT-infected 
BMDCs resembled the V-like shaped phosphosite cluster B (Fig. 1D) for which ERKs kinase 
motif was enriched (Table 1). While not passing the significance level for differential regulation 
in WT- and ΔdsbA-infected BMDCs at 60 min p.i., phosphosite from the activation loop of 
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ERK1 (Y205) followed the trend of ERK2 (Fig. 5B). These findings confirmed ERKs as 
participants in both waves of WT-induced signaling in BMDCs during the first hour of the 
infection. Differential regulation of ERKs and p38 in WT- and ΔdsbA-infected BMDCs affected 
also the phosphorylation state of MAPKAPKs acting downstream (Fig. 5B and 5C). ERK-
dependent phosphorylation of p90 ribosomal protein S6 kinases (RSKs) RSK1 and RSK2 (S352 
and T365, respectively) plays a crucial role in their activation (41, 42). Similarly, p38-induced 
phosphorylation of MAP kinase-activated protein kinase 2 (MAPKAPK2 or MK2) site T320 is a 
part of MK2-activating cascade (43). Downstream of ERKs and p38 lies also mitogen- and 
stress-activated kinase 2 (Msk2) whose activity is positively regulated by phosphorylation of 
T687 (44). As expected, all these sites were significantly more phosphorylated in WT-infected 
BMDCs at 60 min p.i. (Fig. 5B and 5C). Importantly, phosphorylation kinetics paralleled the 
time profiles of phosphosites in activation loops of the respective upstream MAPK (Fig. 5B). 
While there was no direct proof of c-Jun N-terminal kinases (JNKs) involvement in WT-induced 
BMDC signaling at 60 min p.i., the phosphorylation of JNK-interacting protein 3 (JIP3) (45) was 
differentially regulated in WT- and ΔdsbA-infected BMDCs at this time p.i. (Fig. 5C). To 
confirm SILAC-based results, the activation states of ERKs, p38 and RSK1 were assessed by 
Western blot (Fig. 5D). In line with phosphoproteomics data, ERKs and RSK1 were activated in 
both WT- and ΔdsbA-infected BMDCs at 10 min p.i. However, in contrast to WT-infected 
BMDCs, both kinases returned to their near-basal states in ΔdsbA-infected cells at 60 min p.i. As 
expected, the induction of p38 at 60 min p.i. was observed only in BMDCs infected by WT strain 
(Fig. 5D). The described MAPK activation profiles were not biased by the efficiency or by the 
synchronization of the infection (Fig. S9). WT-specific induction of ERKs and p38 at 60 min p.i. 
raised a question whether the altered host signaling could be related to the increased presence of 
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WT in the cytosol (Fig. 2C). Bafilomycin A1 treatment is employed to block Francisella 
phagosomal escape in host cells (46, 47). However, bafilomycin A1 alone was a potent inducer 
of p38 in BMDCs (Fig. S10A) which ruled out its use in this case. Nevertheless, BMDCs treated 
by escape-negative (47) paraformaldehyde (PFA)-killed bacteria showed a similar level of ERK 
activation as in WT-infected cells and only p38 activity was dependent on the viability of 
bacteria (Fig. S10B). Altogether, the results indicate that ERKs and p38 and their downstream 
effectors RSK1, RSK2, Msk2 and MK2 represent major signaling modules specifically induced 
in WT-infected cells at 60 min p.i. and that the induction of p38 branch requires viable bacteria. 
WT-induced p38 signaling regulates the early expression of pro- and anti-inflammatory 
cytokines in infected BMDCs 
The induction of MAPK/MAPKAPK cascades in WT-infected BMDCs suggested that these 
cells might also mobilize their transcriptional machinery. Indeed, the observation of WT-driven 
phosphorylation of proteins associated with inhibitor of NF-κB kinase (IKK) signaling indicated 
the upregulation of gene expression. Tab2 protein, needed for IKKα/β activation, was 
phosphorylated (S450) in WT-infected BMDCs at 60 min p.i. (Table S1). Similarly, a known 
substrate of both canonical IKKs and IKK-related kinases (48) – Tank – was phosphorylated on 
two residues (S107 and S258; Fig. 6A and Table S1, respectively). Finally, IKK targets NF-κB 
inhibitor-ε (IκB-ε; S18) (Fig. 6A), IκB-α (Fig. 6B) and Abin2 (S147) (Table S1) were found to 
be phosphorylated in WT-infected BMDCs at 30 min or 60 min p.i., respectively, and these 
events are known to have a positive impact on NF-κB-dependent gene expression (49, 50). In 
addition, the transcriptional activity of activator protein 1 (AP-1) was also upregulated in 
BMDCs infected by WT as inferred from the phosphorylation of Jun (S73) (Fig. 6A). The 
described situation favored the expression of Il12b in WT-infected BMDCs (Fig. 6D) as the gene 
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transcription is NF-κB- and AP-1-dependent (51, 52). Notably, although the phosphorylation of 
Jun was p38-independent (Fig. 6C), the expression of Il12b relied on p38 activity (Fig. 6E) 
which suggests that WT-induced p38 might support NF-κB-dependent transcription (53). The 
early Il12b expression, followed by IL-12p40 secretion (1-6 h p.i.; Fig. 6D and Fig. S11), was in 
contrast to the situation at 24 h p.i., where the levels of IL-12p40 produced by WT-infected 
BMDCs were below those produced by ΔdsbA-infected cells (Fig. 2B and Fig. S11). The nature 
of the attenuation of IL-12p40 production in WT-infected BMDCs could not be explained on the 
basis of the presented phosphoproteomic data as these describe the very early moments of the 
infection. Nevertheless, several lines of evidence suggested that triggering of 
MAPK/MAPKAPK signaling in WT-infected BMDCs at 60 min p.i. leads to the activation of 
cyclic cAMP-responsive element-binding protein (CREB) which is responsible for the 
transcription of genes with immunosuppressive functions (54). First, InnateDB terms connected 
to events in the nucleus (including “CREB phosphorylation”) were found enriched in the group 
of proteins differentially phosphorylated in WT- and ΔdsbA-infected BMDCs at 60 min p.i. (Fig. 
4B). Second, although none of CREB phosphosites were identified as regulated in 
phosphoproteomic screen, CREB represented an interaction hub in MAPK signaling cluster in 
the constructed protein-protein interaction network (Fig. 5A). CREB-regulated transcription 
coactivator 2 (TORC2) was phosphorylated in WT-infected BMDCs at 60 min p.i. (Table S1) at 
-2 position (S612) to calcineurin binding motif (55). Finally, WT-induced MK2 and Msks 
MAPKAPKs (see above) are able to phosphorylate the regulatory S133 CREB site (56, 57). In 
line with the latter, CREB was phosphorylated to a greater extent in WT-infected BMDCs at 60 
min p.i. (Fig. 6B) in p38-dependent manner (Fig. 6C). Notably, CREB was also phosphorylated 
at 10 min p.i. in both WT- and ΔdsbA-infected BMDCs and the biphasic activation profile in 
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WT-infected cells implied the participation of either ERKs (Fig. 1D and 5B) and/or Akt (see 
Discussion) in the process. The activation of CREB in infected macrophages and DCs leads to 
the expression of anti-inflammatory genes such as Il10 (54). Consistently with WT-induced 
CREB phosphorylation, the increase in Il10 mRNA was more prominent in WT-infected 
BMDCs (Fig. 6D) and the stable expression relied on p38 activity (Fig. 6E). The dominant 
position of MAPK-regulated transcription factors in BMDC transcriptional response to WT 
might seem surprising considering the cytosolic localization of bacteria at 60 min p.i. (Fig. 2C). 
Indeed, cytosolic Francisella is known to induce expression of type I IFN-related genes through 
the activation of interferon-regulatory factor 3 (IRF3) by TANK-binding kinase 1 (TBK1) in 
STING-dependent manner (9, 10, 58, 59). The interaction network in Fig. S8 contained group of 
proteins potentially involved in cytosolic sensing of bacteria (Fig. S12A). However, the cluster 
was relatively small and both participants identified in phosphoproteomic screen, Tank (Fig. 6A) 
and Trafd1 (Fig. S12B), were also shown to participate in the regulation of NF-κB activity (Fig. 
6B) (48, 60, 61). In line with the inconclusive findings, the expression of Ifnb1 was low in both 
WT- and ΔdsbA-infected BMDCs when compared to cells infected by LVS (Fig. S12C). Taken 
together, these results show that signaling cascades responsible for the activation of NF-κB and 
CREB in BMDCs are stimulated during the first hour of WT infection and the induced early 
expression of both Il12b and Il10 genes depends on WT-activated p38 signaling. 
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Discussion 
In this work, we explored phosphorylation signaling of DCs during their early (< 1 hour) 
interactions with either virulent Francisella tularensis subsp. holarctica FSC200 (WT) or its 
avirulent ΔdsbA mutant. Such events are known to be differentially regulated in host cells 
infected by virulent and attenuated strains (7, 62–64) and they represent the initial point of 
divergence in the activation and the immunogenic development of DCs (6). We demonstrate here 
that virulent Francisella triggers two distinct waves of DC protein phosphorylation within the 
first hour of infection (Fig. 6F). The initial phagocytosis-induced DC response (10 min p.i.) 
involves Akt-mediated stimulation of mTOR, the activation of ERK-RSK module, and the 
regulation of Rac/Cdc42 GAPs and GEFs and PAK autophosphorylation. The active role of 
ERKs and mTOR in Francisella internalization was reported before (65, 66), but this is the first 
study to show the involvement of PAKs in the process. Their function however remains unclear 
because PAK activation is associated with macropinocytic uptake (67) which is not the primary 
mechanism of Francisella entry into phagocytes (68). The initial DC response induced by the 
bacterial engulfment rapidly declines at 30 min p.i. The notable exception represents the 
upregulation of IKK signaling (e.g. phosphorylation of IκBs and Tank) which occurs more 
prominently in DCs infected by WT bacterium. The difference between strains becomes even 
more evident at 60 min p.i. when WT induces the new wave of host proteome phosphorylation. 
The most active components of this second signaling peak are ERK1/2-RSK1/2 and p38-MK2 
kinase modules. The lower potency of ΔdsbA to stimulate such response represents an interesting 
feature of the invasion. DsbA protein is TLR2 ligand (69) but it is unlikely that its loss affected 
TLR-dependent MAPK activation because there is no quantitative difference in the initial 
signaling response of DCs to WT and ΔdsbA. Rather, the existence of two temporally separated 
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host phosphorylation waves suggests that infected DCs react to two distinct events. Considering 
the bacterial uptake as the origin of the initial DC response, we speculate that the second 
signaling wave detected at 60 min p.i. might be functionally linked to the rapid escape of WT 
bacteria into the cytosol. Two findings support this notion: i) only viable WT bacteria are able to 
trigger p38 activation and ii) while the majority of ΔdsbA-containing phagosomes lose their 
integrity at 60 min p.i., bacteria are still surrounded by vacuolar membranes and therefore not 
fully released. It is however impossible to conclude whether the activation of p38/ERKs at 60 
min p.i. results from the enhanced cytosolic sensing of bacterial products, WT-specific rapid 
disruption of phagosome, or the activity of unidentified bacterial effector. In this light, it is 
interesting that components of cytosolic DNA-sensing pathways are not among phosphoproteins 
differentially regulated between WT- and ΔdsbA-infected DCs. It was previously shown that 
ΔdsbA of LVS background stimulates the higher production of IFN-β than its WT counterpart 
(70). In contrast, the expression of Ifnb1 in DCs infected by FSC200 WT and ΔdsbA is lower 
than in LVS-infected DCs and virtually indistinguishable from uninfected cells. This suggests 
that the observed upregulation of MAPK signaling in WT-infected BMDCs is unrelated to 
STING-dependent cytosolic sensing of Francisella DNA (9, 10, 58, 59). The activation of 
MAPKs is a part of the host pro-inflammatory response and it is usually associated rather with 
attenuated Francisella strains (62, 63). For example, previous analysis of host phosphoproteome 
showed that p38-target tristetraproline (TPP) was phosphorylated in response to F. novicida 
ΔlpcC mutant and that this positively affected the stability of pro-inflammatory transcripts (63). 
In contrast, we observe p38-mediated TPP phosphorylation (S52; Table S1) and p38-dependent 
Il12b expression rather in DCs infected by virulent strain. These contradictory findings might be 
explained if we consider that the extent of MAPK activity induced by virulent Francisella is 
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assessed only relatively by the comparison with attenuated bacteria. For illustration, mutants 
defective in phagosomal escape are known to prolong the stimulation of TLRs from within the 
phagosome (7) and the comparison of these strains with WTs may lead to the conclusion that 
virulent Francisella avoids MAPK activation. Here, we employ ΔdsbA as a reference. The 
mutant is attenuated and provides protection in vivo (33). However, the production of IL-1β in 
infected DCs suggests that ΔdsbA probably reaches the host cytosol. Such behavior would 
explain the relatively low ability of ΔdsbA to induce TLR-dependent early MAPKs signaling 
when compared to phagosome-residing mutants (7). On the other hand, different kinetics of 
ΔdsbA-driven phagosomal disruption and of the cellular stress connected with the process might 
be responsible for the apparently high MAPKs activity WT-infected DCs at 60 min p.i. 
Collectively, the presented comparative study reveals that the early MAPKs signaling in 
Francisella-infected DCs is selectively engaged rather than suppressed. The preservation of 
mTOR activity observed at 60 min p.i. in WT-activated DCs probably helps to stimulate gene 
transcription and to re-configure the cell metabolism (71). Interestingly, although Akt mediated 
the suppression of mTOR inhibitors during the bacterial entry, mTOR activity at 60 min p.i. was 
partially supported by p38 (Fig. 6C) and possibly also by ERKs (66). The initial pro-
inflammatory directing of WT-infected DCs is however lost in the course of Francisella-DC 
interaction and, in contrast to ΔdsbA-infected cells, DCs infected by virulent bacteria are not 
activated or matured 24 h p.i. Although the transient early activation of p38 and IκB-α 
phosphorylation was in Francisella-infected cells observed before (64), implications for bacterial 
virulence remain unclear. It is known that the activation of p38 helps Francisella to suppress the 
early cell death of the host (72, 73) and to downregulate MHC II (74). We propose that the 
positive regulation of CREB transcription factor is another side effect of p38 activation which 
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favors Francisella-mediated host survival and immunity bypass (54). It was previously shown 
that GSK-3β inhibition led to CREB activation and IL-10 production in LVS-infected 
macrophages (75). Akt-mediated inhibition of GSK-3β could be indeed responsible for CREB 
induction at 10 min p.i. observed in both WT- and ΔdsbA-infected DCs. However, 
phosphorylation of CREB at 60 min p.i. and the early expression of Il10 in DCs infected by WT 
was p38-dependent. Although the levels of secreted IL-10 were below the limit of detection, we 
speculate that p38-dependently produced IL-10 may through autocrine/paracrine stimulation 
instruct DCs to suppress the initial inflammation and to alter the maturation (76). Taken together, 
our phosphoproteomic data show that the very early DC response to Francisella is divided into 
temporally separate phases which correspond to different stages of bacterial infection. We report 
that cytosolic virulent Francisella induces MAPKs and early gene expression and that these 
processes are the earliest events regulated differentially in DCs infected by WT and attenuated 
ΔdsbA strains of fully virulent FSC200 bacterial background. The temporal orchestration of host 
pro-inflammatory pathways therefore represents the integral part of Francisella life-cycle inside 
hijacked DCs. In this regard, the detailed analysis of early-intermediate gene expression in cells 
exposed to the bacterium may provide new insights into how DCs acquire their unproductive 
phenotype. 
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Figure Legends: 
Fig. 1: Protein phosphorylation induced in BMDCs during the first hour of infection by 
Francisella tularensis subsp. holarctica FSC200 (WT) strain. SILAC-labeled BMDCs were 
infected with WT (MOI 50) for 10, 30 or 60 min (Fig. S1) and processed as described in 
Experimental procedures. (A) Histograms of normalized SILAC log2-ratios (Mock/WT) of 
phosphosites from infected BMDCs. Data collected from means of three biological replicates 
with RSD <30%. (B) Count of significantly regulated phosphosites per given time p.i. (Global 
Mean Rank Test, FDR <0.05). (C) Count of phosphosites which were assigned to fuzzy c-means 
clusters. (D) Fuzzy c-means clustered phosphosites from infected BMDCs. (E) Western blot 
analysis of selected kinases. Data are representative from biological duplicate. 
 
Fig. 2: Francisella ΔdsbA mutant stimulates in vitro BMDC activation and maturation. BMDCs 
were infected by FSC200 WT, FSC200 ΔdsbA or LVS at MOI 10 or treated by E. coli LPS (500 
ng/ml) and left for 24 hours. (A) Flow cytometric analysis of cell surface expression of MHC II, 
CD80 and CD86. Histograms are representative from biological triplicate. (B) Concentrations of 
IL-12p40, IL-1β and IL-6 in culture supernatants were determined by ELISA. Data are presented 
as means ± SEM of independent replicates; n = 3; *p <0.05 (Student’s t test). (C) Electron 
micrographs of BMDCs infected by  WT and ΔdsbA at 60 min p.i. (MOI 50). Black arrow shows 
free bacteria in the cytosol. White arrow indicates the damaged phagosomal membrane. Lengths 
of scale bars are 0.2 μm and 0.1 μm for micrographs showing WT and ΔdsbA, respectively. Data 
are representative from biological triplicate. 
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Fig. 3: BMDCs infected by WT maintain mTOR/p70S6K signaling at 60 min p.i. (A) Time-
dependent changes in phosphorylation of known Akt targets in WT- and ΔdsbA-infected 
BMDCs. (B) Time-dependent site phosphorylation in proteins connected to mTOR localization 
to lysosome – all sites were significantly upregulated at 60 min p.i. only in WT-infected BMDCs 
(Global Mean Rank Test, FDR <0.05). Bar graphs show the situation at 60 min p.i. for sites 
quantified only at this time point. Headings of graphs in (A) and (B) contain gene name/protein 
name, Uniprot accession number and phosphosite position. SILAC-based phosphorylation 
changes are expressed as a mean ± SEM (n = 3) of normalized fold change (FC, infected/mock) 
at respective time p.i.; *p <0.05 (Student’s t test applied on normalized SILAC log2-ratios). In 
graphs, “C” designates no change (FC = 1) and up- and downregulated phosphosites are 
represented by positive and negative FC values, respectively. (C) Western blot analysis of 
phosphosites connected to mTOR activity in infected BMDCs. Data are representative from 
biological duplicate. 
 
Fig. 4: Signaling in BMDCs infected by WT and ΔdsbA starts to diverge at 60 min p.i. (A) 
Means of normalized log2-ratios of phosphosites quantified in all three biological replicates of 
SILAC experiment with RSD <30% per given time p.i. in WT-infected BMDCs were correlated 
with the corresponding values of the same site in ΔdsbA-infected cells. Black line represents x = 
y function, red line shows the actual correlation with Pearson coefficient (r) for the given time 
p.i. (B) Innate DB terms enriched in the group of proteins differentially phosphorylated in WT- 
and ΔdsbA-infected BMDCs at 60 min p.i. (Fisher exact test; BH FDR <0.05). Only those terms 
containing at least 3 differentially regulated phosphosites are presented. 
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Fig. 5: ERK and p38 modules are induced in WT-infected BMDCs at 60 min p.i. (A) Protein-
protein interaction network constructed on STRING background containing 80 proteins 
differentially phosphorylated in WT- and ΔdsbA-infected BMDCs at 60 min p.i. (large circles). 
Magnified part shows MAPK interaction cluster. The color of large circles corresponds to the 
absolute value of the difference between means of phosphosite normalized SILAC log2-ratios in 
WT- and ΔdsbA-infected BMDCs at 60 min p.i. The whole network is in Fig. S8. For details see 
Experimental procedures. (B) Time-dependent and (C) 60 min p.i. changes in phosphorylation of 
MAPK-connected phosphosites in WT- and ΔdsbA-infected BMDCs. See Fig. 3 legend for the 
description of the graphs. (D) Western blot analysis of phosphosites connected to MAPKs 
activity in infected BMDCs. Data are representative from biological duplicate. 
 
Fig. 6: p38-regulates the gene expression in WT-infected BMDCs. (A) Time-dependent changes 
in phosphorylation of selected phosphosites in WT- and ΔdsbA-infected BMDCs. (B) 
Phosphorylation of IκB-α and CREB in WT- and ΔdsbA-infected BMDCs (MOI 50) during the 
first hour of infection. (C) Phosphorylation of Jun, CREB and p70S6K in WT-infected BMDCs 
at 60 min p.i. Cells were pre-treated either by DMSO or p38-inhibitor SB203580 for 60 min 
prior to infection. (D) Stable expression of Il12b and Il10 mRNA in WT- and ΔdsbA-infected 
BMDCs (MOI 50) and in mock-treated cells during 4 h p.i. (E) Stable expression of Il12b and 
Il10 mRNA at 2 h p.i. in WT-infected BMDCs. Cells were pre-treated either by DMSO or p38-
inhibitor SB203580 for 60 min prior to infection. (F) A model of phosphorylation-mediated early 
DC signaling in response to infection by Francisella tularensis subsp. holarctica FSC200. For 
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the description of graphs in (A), see Fig. 3 legend. The changes in mRNA transcription in (D) 
and (E) are expressed as a mean ± SEM (n = 3) FC (infected over mock left for 1 h); *p <0.05 
(Student’s t test applied on ΔΔCt values from WT- and ΔdsbA-infected BMDCs). In graphs, “C” 
designates no change (FC = 1). Western blots are representative from biological duplicates. 
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Tables: 
Table 1: HPRD motifs enriched in phosphosite clusters from Fig. 1D. Motifs were found by 
Fisher exact test (BH FDR <0.05). Only those with enrichment factor >1.2 are presented. None 
motif was found for cluster C. 
Cluster HPRD motif Enrichment factor FDR 
A p70 Ribosomal S6 kinase 2.33 3.02×10-7 
 Aurora-A kinase 1.97 6.82×10-4 
 Phosphorylase kinase 1.64 1.50×10-5 
 Akt kinase 1.57 3.82×10-4 
 MAPKAPK1 kinase 1.55 2.39×10-4 
 PAK2 kinase 1.53 2.65×10-3 
 PKC epsilon kinase 1.46 6.21×10-3 
 MAPKAPK2 kinase 1.30 7.85×10-3 
 14-3-3 domain binding motif 1.27 2.05×10-4 
 Calmodulin-dependent protein kinase II 1.21 1.30×10-3 
B Growth associated histone HI kinase 1.48 2.38×10-3 
 ERK1,2 kinase 1.26 7.96×10-5 
 WW domain binding motif 1.21 3.31×10-4 
 GSK-3, ERK1, ERK2, CDK5 1.21 3.68×10-4 
D Calmodulin-dependent protein kinase I 2.10 1.14×10-2 
 AMP-activated protein kinase 1.70 1.49×10-2 
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Fig. 6 
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